DWM
AGN

Darwin Wealth Management’s Allergan plc AGN Stock Holding History

Darwin Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50
Closed -$8K – 875
2020
Q1 		$8K Buy
+50
New +$9.41K ﹤0.01% 532

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Darwin Wealth Management's AGN Position: Q2 2020 in Review

Darwin Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 50 shares — an estimated $8K sold.

Darwin Wealth Management first reported a position in AGN in Q1 2020 and held it in 1 quarter. The position peaked at $8K in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Darwin Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Darwin Wealth Management sold 50 Allergan plc shares in Q2 2020, an estimated $8K.
  • Darwin Wealth Management first reported a position in Allergan plc in Q1 2020 and held it in 1 quarter.
  • Darwin Wealth Management's Allergan plc position peaked at $8K in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Darwin Wealth Management's 13F filing for Q2 2020, filed 6 Aug 2020.